JPN is the Journal of Psychiatry & Neuroscience, a leading scientific publication that focuses on the intersection of psychiatry and neuroscience. The journal publishes research papers that advance our understanding of the neural mechanisms involved in the etiology and treatment of psychiatric disorders. This includes studies on patients with psychiatric disorders, healthy humans, and experimental animals, as well as studies conducted in vitro.

JPN offers a range of original research articles, including clinical trials with a mechanistic component, and review papers. As an open access journal, all articles published in JPN are freely available on their website and PubMed Central. JPN is owned by CMA Impact Inc., a subsidiary of the Canadian Medical Association.

The journal has a high impact factor of 4. 3 (2022), indicating its significance and influence in the field. JPN is grateful for the anonymous and unpaid work of its reviewers, whose contributions are vital in maintaining the journal's quality and relevance.

The journal also acknowledges the Indigenous Peoples of Canada and their traditional lands. For researchers, clinicians, and individuals interested in the latest developments in psychiatry and neuroscience, JPN provides a valuable resource for staying informed and contributing to the field